May 19, 2017 - Merck & Co., Inc. (MRK) announced that the FDA has approved two new indications for Keytruda (pembrolizumab), the company's anti-PD-1 therapy.
May 17, 2017 - It looks like a great stock to buy now.
May 15, 2017 - AstraZeneca PLC (AZN) recently announced positive data from a phase III PACIFIC study evaluating its oncology candidate, Imfinzi (durvalumab).
May 12, 2017 - While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs.
May 11, 2017 - The Zacks Analyst Blog Highlights: Merck, Barclays, Activision Blizzard, Blackstone and Tyson Foods
May 10, 2017 - Top Research Reports for Activision Blizzard, Merck and Barclays
May 10, 2017 - Our overall "Medical" sector is up about 7.78% year-to-date, which just edges out the gains of the S&P 500. Within this broad sector, one of the better performing industries has been what we call "Large Cap Pharmaceuticals."
May 10, 2017 - Top Ranked Income Stocks to Buy for May 10th
May 10, 2017 - There's little better than a quick 100% gain. These stock have the potential to deliver just that.
May 10, 2017 - Celldex Therapeutics, Inc. (CLDX) posted first-quarter 2017 loss of 28 cents per share, which was in line with the Zacks Consensus Estimate